Produktinformation
- Carbaglu, N-Carbamylglutamate, N-Carbamyl-L-glutamic acid, Carbamylglutamic acid, Carbamino-L-glutamic acid, Ureidoglutaric acid
- (2S)-2-(Carbamoylamino)pentanedioic acid
- (S)-2-Ureidopentanedioic acid
- <span class="text-smallcaps">L</span>-Glutamic acid, N-(aminocarbonyl)-
- Carbaglu
- Carbamino-<span class="text-smallcaps">L</span>-glutamic acid
- Carbamino-L-glutamic acid
- Carbamylglutamic acid
- Carglumic acid
- Carglumic acid [INN]
- Mehr Synonyme anzeigen
- Glutamic acid, N-carbamoyl-, <span class="text-smallcaps">L</span>-
- Glutamic acid, N-carbamoyl-, L- (8CI)
- L-Glutamic acid, N-(aminocarbonyl)-
- L-N-Carbamoylglutamic acid
- N-(Aminocarbonyl)-<span class="text-smallcaps">L</span>-glutamic acid
- N-(aminocarbonyl)-L-Glutamic acid
- N-Carbamoyl-<span class="text-smallcaps">L</span>-glutamic acid
- N-Carbamoyl-L-glutamic acid
- N-Carbamoyl-S-glutamic acid
- N-Carbamyl-<span class="text-smallcaps">L</span>-glutamic acid
- N-Carbamylglutamate
- NCG
- Oe 312
- Ucedane
- Unii-5L0Hb4V1Ew
- Ureidoglutaric acid
Carglumic Acid (Ureidoglutaric acid) is an orphan drug used to treat hyperammonemia in patients with N-acetyl glutamate synthase absence. This rare hereditary disease results in elevated blood levels of ammonia, which can eventually cross the blood-brain barrier and lead to neurologic problems, coma, cerebral edema, and death. Carglumic acid was approved by the U.S. FDA on 18 March 2010.
Chemische Eigenschaften
Technische Anfrage zu: TM-T0755 Carglumic Acid
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.